Skip to main content
. Author manuscript; available in PMC: 2013 Nov 21.
Published in final edited form as: Gastrointest Endosc. 2012 Feb 15;75(5):10.1016/j.gie.2011.12.014. doi: 10.1016/j.gie.2011.12.014

Table 3.

Management Approach to Anticoagulation During Gastrointestinal Bleeding Episodes

All patients HM II device
Management Approach n=34 n=29
Acute Management
  Fresh frozen plasma 11 (32.4%) 8 (27.5%)
  Vitamin K 1 (2.9%) 1 (3.5%)
  Warfarin held only 22 (64.7%) 20 (69.0%)
Chronic Management
  Warfarin Continued 23 (67.7%) 19 (65.5%)
  Warfarin Stopped 11 (32.3%) 10 (35.5%)